Funding · Company
Verismo Therapeutics, Inc.
Philadelphia, PAHealthcare
Verismo Therapeutics, Inc. of Philadelphia, PA has disclosed $28M across 1 Form D offering filed with the SEC on May 20, 2026.
$28M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersPhiladelphia, PAIndustryHealthcare (Other Health Care)SEC CIK0001855431Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →